Enzoimmune Active against Herpes Simplex, final report of the National Center for Infectious and Parasitic Diseases (NCIPD)

This is the final report of the National Center for Infectious and Parasitic Diseases (NCIPD) on: “Study of the antiviral effect of Inactivated Pepsin Fragment (IPF) an active ingredient of the substance Enzoimmune Active on the replication of human Herpes Simplex viruses type 1 and type 2 (HSV-1/HSV-2) in cell cultures, including determination of basic chemotherapeutic parameters – Inhibitory Concentration 50% and Selectivity Index (SI)”. You may read the report by clicking the button bellow.

Read The Report